Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
In today's rapidly evolving biotechnology and pharmaceutical landscape, the demand for robust cold chain logistics has reached unprecedented heights. The increasing popularity of advanced therapy medicinal products (ATMPs) like cell and gene therapies, mRNA vaccines, and other temperature-sensitive pharmaceuticals has spurred this growth, necessitating innovative, technology-driven cold chain capabilities for both clinical and commercial products.
Our recent webinar, featuring Susan Li, Sr. Director of Cold Chain Logistics, Cell and Gene Therapy Solutions at Thermo Fisher Scientific, explored this topic, revealing the challenges and opportunities associated with cold and ultra-cold supply chain logistics. It showcased advanced solutions to streamline the storage, packaging, labeling, and distribution of high-value therapies, ensuring their integrity and efficacy from clinical development through to commercial distribution.
Key webinar insights include:
If you’re a drug developer of temperature-sensitive advanced therapy medicinal products (ATMPs), this is a webinar you don’t want to miss. Explore the advantages of industry-leading cold chain logistics, preserving the safety of your products while transporting them to patients in need.
About the speaker:
Susan Li joined Thermo Fisher Scientific in November 2020 as the director of customer solutions and subject matter expert (SME) for cell and gene therapy. She and her team developed innovative and customized solutions to support clients in conducting global clinical trials and commercial distribution. In May 2023, Susan was promoted to the senior director of client services and solution services, where she works to enhance collaboration across the group to provide best-in-class customer experience and onboarding support.
Susan brings expertise in cell therapy supply chain solutions from her role at Celgene (now Bristol Myers Squibb) as the director of cell therapy logistics, where she developed clinical and commercial supply chain strategies to support the launch of autologous CAR-T cell therapy products. She was also a healthcare cold chain logistics strategist at UPS and has marketing and commercial operations experience from Abbott Laboratories, along with drug discovery research knowledge as a molecular biologist from AstraZeneca.